A landmark achievement in Nigerian pharmaceutical governance, NAFDAC’s enhanced Med Safety App now provides digital reporting capabilities to over 200 million citizens. This expansion of accessible reporting infrastructure represents a critical advancement in addressing substandard and falsified medicines within Nigeria’s pharmaceutical supply chain.
The platform democratizes pharmaceutical surveillance by removing traditional barriers to reporting. Healthcare workers and members of the public can submit suspected counterfeit medicines and adverse drug reaction reports through an intuitive mobile interface. This broad accessibility is essential given that counterfeit medications remain a significant public health challenge in Nigeria, potentially affecting millions of patients who depend on reliable pharmaceutical products for treatment.
Was this article helpful?
